- Presentations
- 3
- Markets
- 1
Ninlaro is a brand of Ixazomib marketed by Takeda Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ixazomib
- Brand owner
- Takeda Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 2.3 mg capsule, 3 mg capsule, 4 mg capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ninlaro 2.3 mg capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
| Ninlaro 3 mg capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
| Ninlaro 4 mg capsuleOral | Takeda Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ninlaro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.